| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000003762 |
| Receipt No. | R000004556 |
| Official scientific title of the study | Effect of local steroid injection or application on the epithelial regeneration promoting action of postoperative artificial ulcer following endoscopic submucosal dissection in early-stage esophageal cancer - Preventing esophageal stenosis due to scar formation during the epithelial regeneration process |
| Date of disclosure of the study information | 2010/06/15 |
| Last modified on | 2016/08/15 (Ver. 12) |
| Basic information | ||
| Official scientific title of the study | Effect of local steroid injection or application on the epithelial regeneration promoting action of postoperative artificial ulcer following endoscopic submucosal dissection in early-stage esophageal cancer
- Preventing esophageal stenosis due to scar formation during the epithelial regeneration process |
|
| Title of the study (Brief title) | Kenacort injection or application for the esophagus | |
| Region |
|
|
| Condition | ||
| Condition | Early esophageal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Local steroid injection or application therapy is effective for preventing esophageal stricture after endoscopic submucosal dissection (ESD). We evaluated the effectiveness of triamcinolone acetonide (TA) application followed by balloon dilatation compared to steroid injection and application following endoscopic submucosal dissection for esophageal cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary outcome measure was the difference in stricture rate between groups determined by gastrografin esophagograms on PODs 5, 8, 12, 15, 20, 30, and 60 between 2 gouups. |
| Key secondary outcomes | The number of EBD procedures, the number of procedure-related bleeding events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||||
| No. of arms | 2 | |||
| Purpose of intervention | Treatment | |||
| Type of intervention |
|
|||
| Interventions/Control_1 | In the local steroid injection group, 0.2 ml (2 mg) TA was locally injected into the ulcer floor at 8 mm intervals with extra care to avoid injection and following 5 min balloon dilatation (12-15 mm in diameter) was performed on PODs 5, 8, 12, and 15. Gastrografin esophagograms was also taken on PODs 5, 8, 12, 15, 20, 30, and 60. The 45-degree RAO position to evaluate esophageal stricture.
|
|||
| Interventions/Control_2 | In the steroid gel application group on each PODs 5, 8, 12, and 15 triamcinolone acetonide (TA) gel was locally applied onto the ulcer floor and following balloon dilatation was performed immediately. The TA gel was made and applied as follows: total of 10 ml TA (100 mg) was mixed with 7.5 ml Endolubri jelly to make 17.5 ml of gel | |||
| Interventions/Control_3 | ||||
| Interventions/Control_4 | ||||
| Interventions/Control_5 | ||||
| Interventions/Control_6 | ||||
| Interventions/Control_7 | ||||
| Interventions/Control_8 | ||||
| Interventions/Control_9 | ||||
| Interventions/Control_10 | ||||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with early-stage esophageal cancer who had undergone endoscopic submucosal dissection with an excision of three fourths to the full circumference of the esophagus from whom informed consent was obtained | |||
| Key exclusion criteria | nothing in particular | |||
| Target sample size | 45 | |||
| Research contact person | |
| Name of lead principal investigator | Hirohito Mori |
| Organization | Kagawa University |
| Division name | Department of gastroenterology |
| Address | 1750-1 ooaza ikenobe miki town kida county kagawa prefecture |
| TEL | 087-891-2156 |
| hiro4884@med.kagawa-u.ac.jp | |
| Public contact | |
| Name of contact person | Shintaro Fujhara |
| Organization | Kagawa University |
| Division name | Department of gastroenterology |
| Address | 1750-1 ooaza ikenobe miki town kida county kagawa prefecture |
| TEL | 087-891-2156 |
| Homepage URL | |
| joshin@med.kagawa-u.ac.jp | |
| Sponsor | |
| Institute | Kagawa University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kagawa University |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | The study (UMIN000005546,3743) was reregistered and was discontinued.
This study was original version. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004556 |